東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The effect of direct-to-consumer adv...

Hansen, Richard Aaron.

Linked to FindBook

Google Book

Amazon

博客來

The effect of direct-to-consumer advertising on prescription drug use among the insured.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The effect of direct-to-consumer advertising on prescription drug use among the insured./
Author:	Hansen, Richard Aaron.
Description:	268 p.
Notes:	Source: Dissertation Abstracts International, Volume: 64-07, Section: B, page: 3214.
Contained By:	Dissertation Abstracts International64-07B.
Subject:	Health Sciences, Pharmacy. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3098595
ISBN:	0496461996

The effect of direct-to-consumer advertising on prescription drug use among the insured.
Hansen, Richard Aaron.

The effect of direct-to-consumer advertising on prescription drug use among the insured. - 268 p.

Source: Dissertation Abstracts International, Volume: 64-07, Section: B, page: 3214.

Thesis (Ph.D.)--University of Minnesota, 2003.

Since August of 1997, when the Food and Drug Administration issued a draft guidance for direct-to-consumer advertising of prescription drugs, consumer directed advertising has become a major part of the prescription drug market. Accompanied by the increasing presence of prescription drug insurance, prescription drug utilization and spending has increased dramatically over the last decade. The objective of this research was to investigate the effect of direct-to-consumer advertising on prescription drug use. This study was designed specifically to investigate the effect of advertising on product use in insured populations, hypothesizing that there is an interaction between the amount of money that consumers pay out of pocket and direct-to-consumer advertising.

ISBN: 0496461996Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

The effect of direct-to-consumer advertising on prescription drug use among the insured.
LDR:03121nmm 2200301 4500 001 1838197
005 20050512080246.5
008 130614s2003 eng d
020 $a 0496461996
035 $a (UnM)AAI3098595
035 $a AAI3098595
040 $a UnM $c UnM
100 1 $a Hansen, Richard Aaron. $3 1926619
245 1 4 $a The effect of direct-to-consumer advertising on prescription drug use among the insured.
300 $a 268 p.
500 $a Source: Dissertation Abstracts International, Volume: 64-07, Section: B, page: 3214.
500 $a Adviser: Jon C. Schommer.
502 $a Thesis (Ph.D.)--University of Minnesota, 2003.
520 $a Since August of 1997, when the Food and Drug Administration issued a draft guidance for direct-to-consumer advertising of prescription drugs, consumer directed advertising has become a major part of the prescription drug market. Accompanied by the increasing presence of prescription drug insurance, prescription drug utilization and spending has increased dramatically over the last decade. The objective of this research was to investigate the effect of direct-to-consumer advertising on prescription drug use. This study was designed specifically to investigate the effect of advertising on product use in insured populations, hypothesizing that there is an interaction between the amount of money that consumers pay out of pocket and direct-to-consumer advertising.
520 $a A modified retrospective cohort design was used for this study. Data were obtained from MEDSTAT MarketScanRTM and Competitive Media Reporting (CMR). The sample population included insured individuals aged sixty-four or younger with continuous enrollment in one of the employer sponsored insurance plans included in the MEDSTAT dataset from July 1, 1997 through December 31, 1998. Forty-seven defined market areas (DMA) were included in the final sample of 396,500 enrollees. These markets were matched to advertising expenditure data provided by CMR for the proton pump inhibitor market. The only drug in this market for which there was direct-to-consumer advertising was PrilosecRTM, marketed by Astra Zeneca. Prevacid, the only other proton pump inhibitor on the market at this time, did not advertise direct-to-consumer.
520 $a The results of the study showed that both Prilosec and Prevacid use were affected significantly by the interaction between insured consumers' out-of-pocket cost and the level of direct-to-consumer advertising. The interaction terms were significant for incident use as well as duration of use, where the most significant interaction was found among individuals that paid average amounts out-of-pocket and potentially were exposed to higher levels of advertising. In this market, the effect of direct-to-consumer advertising appears to be dependent on the insured beneficiary's out-of-pocket cost.
590 $a School code: 0130.
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Health Sciences, Public Health. $3 1017659
690 $a 0572
690 $a 0573
710 2 0 $a University of Minnesota. $3 676231
773 0 $t Dissertation Abstracts International $g 64-07B.
790 1 0 $a Schommer, Jon C., $e advisor
790 $a 0130
791 $a Ph.D.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3098595